Drug
Who makes nh3n13?
5 companies list nh3n13 as a human prescription drug, including under the names Ammonia N 13. Forms: injection. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing nh3n13
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| The Feinstein Institutes for Medical ResearchUnited States | injection | NDANDA022119 | 1 | 1 |
| The Johns Hopkins UniversityUnited States | injection | ANDAANDA204514 | 1 | 1 |
| UCSF Radiopharmaceutical FacilityUnited States | injection | ANDAANDA204496 | 1 | 1 |
| University of Alabama at BirminghamUnited States | injection | ANDAANDA211698 | 1 | 1 |
| Washington University School of Medicine | injection | ANDAANDA204506 | 1 | 0 |
Enquiry
Common questions
- Who makes nh3n13?
- 5 companies list nh3n13 as a human prescription drug in the openFDA NDC Directory, led by The Feinstein Institutes for Medical Research, The Johns Hopkins University, UCSF Radiopharmaceutical Facility, University of Alabama at Birmingham, Washington University School of Medicine. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic Ammonia N 13?
- 4 companies list nh3n13 under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.